高雄醫學大學圖書館 |

Epigenetic Regulation of Hepatitis B Virus In Vivo /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Epigenetic Regulation of Hepatitis B Virus In Vivo // Rachel Matrenec Collopy.
Author:	Collopy, Rachel Matrenec,
Description:	1 electronic resource (106 pages)
Notes:	Source: Dissertations Abstracts International, Volume: 86-04, Section: B.
基督教聖經之智慧書導讀 :	Chronic hepatitis B virus (HBV) infection is a global public health concern responsible for nearly 1 million deaths annually. Current mainstays of HBV treatment, nucleoside analogs and interferon, are associated with drug resistance and negative side effects. Most importantly, these treatments are not curative and only slow the progression of chronic HBV, which frequently leads to significant liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Chronic HBV infection is maintained by viral covalently closed circular (ccc) DNA, a highly stable replication product and transcriptional template which exists as an episome in the nucleus. As such, the epigenetic silencing of nuclear HBV DNA represents one potential mechanism that may address curing chronic HBV infection. The limited coding capacity of the virus leaves few viral drug targets. As such, targeting host cellular factors that contribute to successful HBV replication is imperative. This current study explores the roles of Foxa and Ten-eleven translocation (Tet) methylcytosine dioxygenases in the epigenetic regulation of HBV DNA.Liver-specific Foxa- and Tet-deficient HBV transgenic mice are useful in vivo models of chronic HBV infection. HBV cccDNA is associated with histones and assembled into chromatin in patients. It is likely subject to regulation similar to that of the HBV transgene in this mouse model. Liver-specific Foxa-deficient HBV transgenic mice do not replicate HBV due to the specific transcriptional silencing of the viral DNA as a result of methylation. The methylation of the HBV DNA is observed in these mice regardless of which Foxa factor is deleted, suggesting that the level of Foxa factor activity governs the demethylation of the HBV transgene, rather than the expression of any specific Foxa factor. Similarly, Tet-deficient HBV transgenic mice display high levels of viral DNA methylation and very low levels of viral transcription and replication. Together, these observations suggest that Foxa and/or Tet enzymes are viable drug targets that may offer resolution of chronic HBV infection.
Contained By:	Dissertations Abstracts International86-04B.
Subject:	Immunology. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=31693775
ISBN:	9798384461111

Epigenetic Regulation of Hepatitis B Virus In Vivo /
Collopy, Rachel Matrenec,

Epigenetic Regulation of Hepatitis B Virus In Vivo /Rachel Matrenec Collopy. - 1 electronic resource (106 pages)

Source: Dissertations Abstracts International, Volume: 86-04, Section: B.

Chronic hepatitis B virus (HBV) infection is a global public health concern responsible for nearly 1 million deaths annually. Current mainstays of HBV treatment, nucleoside analogs and interferon, are associated with drug resistance and negative side effects. Most importantly, these treatments are not curative and only slow the progression of chronic HBV, which frequently leads to significant liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Chronic HBV infection is maintained by viral covalently closed circular (ccc) DNA, a highly stable replication product and transcriptional template which exists as an episome in the nucleus. As such, the epigenetic silencing of nuclear HBV DNA represents one potential mechanism that may address curing chronic HBV infection. The limited coding capacity of the virus leaves few viral drug targets. As such, targeting host cellular factors that contribute to successful HBV replication is imperative. This current study explores the roles of Foxa and Ten-eleven translocation (Tet) methylcytosine dioxygenases in the epigenetic regulation of HBV DNA.Liver-specific Foxa- and Tet-deficient HBV transgenic mice are useful in vivo models of chronic HBV infection. HBV cccDNA is associated with histones and assembled into chromatin in patients. It is likely subject to regulation similar to that of the HBV transgene in this mouse model. Liver-specific Foxa-deficient HBV transgenic mice do not replicate HBV due to the specific transcriptional silencing of the viral DNA as a result of methylation. The methylation of the HBV DNA is observed in these mice regardless of which Foxa factor is deleted, suggesting that the level of Foxa factor activity governs the demethylation of the HBV transgene, rather than the expression of any specific Foxa factor. Similarly, Tet-deficient HBV transgenic mice display high levels of viral DNA methylation and very low levels of viral transcription and replication. Together, these observations suggest that Foxa and/or Tet enzymes are viable drug targets that may offer resolution of chronic HBV infection.

English

ISBN: 9798384461111Subjects--Topical Terms:

187040
Immunology.
Subjects--Index Terms:

Hepatitis B virus

Epigenetic Regulation of Hepatitis B Virus In Vivo /
LDR:03709nam a22004693i 4500 001 391468
005 20251124054801.5
006 m o d
007 cr|nu||||||||
008 251208s2024 miu||||||m |||||||eng d
020 $a 9798384461111
035 $a (MiAaPQD)AAI31693775
035 $a (MiAaPQD)0799vireo565Collopy
035 $a AAI31693775
040 $a MiAaPQD $b eng $c MiAaPQD $e rda
100 1 $a Collopy, Rachel Matrenec, $e author. $3 523995
245 1 0 $a Epigenetic Regulation of Hepatitis B Virus In Vivo / $c Rachel Matrenec Collopy.
264 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2024
300 $a 1 electronic resource (106 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 86-04, Section: B.
500 $a Advisors: Oberstein, Adam; McLachlan, Alan Committee members: He, Bin; Petukhov, Pavel; Federle, Michael.
502 $b Ph.D. $c University of Illinois at Chicago $d 2024.
520 $a Chronic hepatitis B virus (HBV) infection is a global public health concern responsible for nearly 1 million deaths annually. Current mainstays of HBV treatment, nucleoside analogs and interferon, are associated with drug resistance and negative side effects. Most importantly, these treatments are not curative and only slow the progression of chronic HBV, which frequently leads to significant liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Chronic HBV infection is maintained by viral covalently closed circular (ccc) DNA, a highly stable replication product and transcriptional template which exists as an episome in the nucleus. As such, the epigenetic silencing of nuclear HBV DNA represents one potential mechanism that may address curing chronic HBV infection. The limited coding capacity of the virus leaves few viral drug targets. As such, targeting host cellular factors that contribute to successful HBV replication is imperative. This current study explores the roles of Foxa and Ten-eleven translocation (Tet) methylcytosine dioxygenases in the epigenetic regulation of HBV DNA.Liver-specific Foxa- and Tet-deficient HBV transgenic mice are useful in vivo models of chronic HBV infection. HBV cccDNA is associated with histones and assembled into chromatin in patients. It is likely subject to regulation similar to that of the HBV transgene in this mouse model. Liver-specific Foxa-deficient HBV transgenic mice do not replicate HBV due to the specific transcriptional silencing of the viral DNA as a result of methylation. The methylation of the HBV DNA is observed in these mice regardless of which Foxa factor is deleted, suggesting that the level of Foxa factor activity governs the demethylation of the HBV transgene, rather than the expression of any specific Foxa factor. Similarly, Tet-deficient HBV transgenic mice display high levels of viral DNA methylation and very low levels of viral transcription and replication. Together, these observations suggest that Foxa and/or Tet enzymes are viable drug targets that may offer resolution of chronic HBV infection.
546 $a English
590 $a School code: 0799
650 4 $2 96060 $a Immunology. $3 187040
650 4 $2 96060 $a Microbiology. $3 187154
650 4 $2 96060 $a Genetics. $3 202246
650 4 $2 96060 $a Virology. $3 187922
653 $a Hepatitis B virus
653 $a Hepatocellular carcinoma
653 $a DNA methylation
653 $a Foxa
653 $a Epigenetic modification
690 $a 0720
690 $a 0369
690 $a 0982
690 $a 0410
710 2 $a University of Illinois at Chicago. $b Microbiology and Immunology. $e degree granting institution. $3 523996
720 1 $a Oberstein, Adam $e degree supervisor.
720 1 $a McLachlan, Alan $e degree supervisor.
773 0 $t Dissertations Abstracts International $g 86-04B.
790 $a 0799
791 $a Ph.D.
792 $a 2024
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=31693775